PRECLINICAL ONCOLOGY · LYON, FRANCE

Your partner for preclinical studies in oncology

From early research to proof of concept, move your oncology programme forward with Antineo.

SCIENCE WITH A CLEAR PURPOSE

Expertise built around
your research.

Antineo is a Contract Research Organization specialised in proof-of-concept studies in oncology. We support private companies and academic institutions with preclinical services and scientific expertise.

OUR PRECLINICAL SERVICES

From in vitro to in vivo.

Complementary approaches. One scientific partner.

In vitro

From screening to cellular response.

Ex vivo

Explore responses in biological samples.

In vivo

Evaluate your candidate in tumour models.

PRECLINICAL TUMOUR MODELS

The right model.
The next step forward.

Explore our model families and find a starting point for your oncology programme.

Syngeneic models

Study tumour response in an immunocompetent setting.

Cell-derived xenografts

Explore a range of human tumour cell lines.

Patient-derived xenografts

Bring patient tumour material into your research.

Resistant models

Investigate treatment resistance with original models.

TAILORED TO YOUR PROJECT

Your question.
A study designed for it.

Bring your research objectives to our team. Together, we can discuss the approach, models and study design that fit your project.

01 / DISCUSS

Define your objectives

Share your scientific question and the decision your study needs to inform.

02 / DESIGN

Build the right approach

Discuss the experimental models and readouts with our team.

03 / STUDY

Move your research forward

Connect preclinical expertise with your development programme.

CLIENT EXPERIENCES

A partner in your progress.

Antineo provided a great service starting with the expert advice on the study design. Their characterized resistance models enabled us to realize a superb efficacy of our lead compound in their in vivo model for pancreatic cancer. Antineo is a trusted partner for our preclinical development.

Alexander Scheer

CasInvent

We worked with Antineo right from the maturation phase of our project, and continued to do so after the company was created. Our studies have always been carried out with competence, rigor, relevance, responsiveness and availability. There’s no doubt that we’ll be calling on them again in the course of our development to cover our preclinical needs.

Camille Granet

Yomi Pharma

We have really benefited from Antineo expertise in preclinical services which has allowed us to establish proof of concept in xenograft models that they have identified, in-licensed and developed for us. Project management is very professionally done with regular reporting in a proactive mode. It is really nice to work with the whole team!

Cécile Bougeret

Evextabio

LET’S TALK SCIENCE

What’s next for
your research?

Tell us about your project. Let’s explore the possibilities together.